title: Do we need more intensive enzyme replacement therapy for Anderson-Fabry disease?
authors.forename: Nikolina
authors.initials: N
authors.lastname: Basic-Jukic
authors.forename: Petar
authors.initials: P
authors.lastname: Kes
authors.forename: Ivica
authors.initials: I
authors.lastname: Mokos
authors.forename: Marijana
authors.initials: M
authors.lastname: Coric
mesh_terms: D004311:Double-Blind Method; D000795:Fabry Disease / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D005919:Glomerular Filtration Rate; D007527:Isoenzymes / Q000627:therapeutic use*; D016030:Kidney Transplantation; D000519:alpha-Galactosidase / Q000627:therapeutic use*
chemical_list: D007527:Isoenzymes; D000519:alpha-Galactosidase; C459420:agalsidase beta